A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

被引：0
|
作者：
Bernd Hoppe
Patrick Niaudet
Rémi Salomon
Jérôme Harambat
Sally-Anne Hulton
William Van’t Hoff
Shabbir H. Moochhala
Georges Deschênes
Elisabeth Lindner
Anna Sjögren
Pierre Cochat
机构：
[1] University Hospital Bonn,Department of Pediatrics, Division of Pediatric Nephrology
[2] Université Paris-Descartes,Pediatric Nephrology, Necker Hospital
[3] Centre Hospitalier Universitaire de Bordeaux,Centre de référence Maladies Rénales Rares du Sud
[4] Birmingham Children’s Hospital NHS Foundation Trust,Ouest
[5] Great Ormond Street Hospital,Department of Paediatric Nephrology
[6] Royal Free Campus and Hospital,Renal Unit
[7] Robert Debré Hospital,UCL Centre for Nephrology
[8] OxThera AB,Pediatric Nephrology Department
[9] Hôpital Femme Mère Enfant,Centre de référence des Maladies Rénales Rares
来源：
Pediatric Nephrology | 2017年 / 32卷
关键词：
Primary hyperoxaluria; Oxalate; Kidney; Kidney function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：781 / 790
页数：9
相关论文
共 50 条
  • [41] Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease
    Lutz Frölich
    Glen Wunderlich
    Claus Thamer
    Michael Roehrle
    Miguel Garcia
    Bruno Dubois
    Alzheimer's Research & Therapy, 11
  • [42] TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma
    Davies, Alice
    Sage, Beth
    Kolluri, Krishna
    Alrifai, Doraid
    Graham, Rebecca
    Weil, Ben
    Rego, Rita
    Bain, Owen
    Patrick, P. Stephen
    Champion, Kim
    Day, Alex
    Popova, Bilyana
    Wheeler, Graham
    Fullen, Dan
    Kalbur, Tammy
    Forster, Martin
    Lowdell, Mark
    Janes, Sam
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
    Verstovsek, Srdan
    Foltz, Lynda
    Gupta, Vikas
    Hasserjian, Robert
    Manshouri, Taghi
    Mascarenhas, John
    Mesa, Ruben
    Pozdnyakova, Olga
    Ritchie, Ellen
    Veletic, Ivo
    Gamel, Katia
    Hamidi, Habib
    Han, Lyrialle
    Higgins, Brian
    Trunzer, Kerstin
    Uguen, Marianne
    Wang, Dao
    El-Galaly, Tarec Christoffer
    Todorov, Boyan
    Gotlib, Jason
    HAEMATOLOGICA, 2023, 108 (10) : 2730 - 2742
  • [44] Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial
    Yen, C.
    Kim, T. Y.
    Feng, Y. H.
    Chao, Y.
    Lin, D. Y.
    Studeny, M.
    Hocke, J.
    Huang, D. C. L.
    Ryoo, B. Y.
    Cheng, A. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S612 - S612
  • [45] Phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab (AMG 334) in migraine prevention: Primary results of the STRIVE trial
    Reuter, Uwe
    Bonner, Jo
    Broessner, Gregor
    Hallstrom, Yngve
    Zhang, Feng
    Sapra, Sandhya
    Picard, Hernan
    Mikol, Daniel D.
    Lenz, Robert A.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [46] PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB (AMG 334) IN MIGRAINE PREVENTION: PRIMARY RESULTS OF THE STRIVE TRIAL
    Goadsby, Peter J.
    Reuter, Uwe
    Bonner, Jo
    Broessner, Gregor
    Hallstrom, Yngve
    Zhang, Feng
    Sapra, Sandhya
    Picard, Hernan
    Mikol, Daniel
    Lenz, Robert
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [47] A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma
    Stacy, Rebecca
    Huttner, Kenneth
    Watts, Jen
    Peace, James
    Wirta, David
    Walters, Tom
    Sall, Kenneth
    Seaman, John
    Ni, Xiao
    Prasanna, Ganesh
    Mogi, Muneto
    Adams, Christopher
    Yan, Jing-He
    Wald, Michael
    He, Yunsheng
    Newton, Ronald
    Kolega, Randall
    Grosskreutz, Cynthia
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 192 : 113 - 123
  • [48] Results of a randomised, multicentre, phase II, dose-ranging clinical study to assess the safety and efficacy of fixed dose, orally administered pyronaridine and artesunate in adult patients with acute uncomplicated Plasmodium falciparum malaria
    Looareesuwan, Sornchai
    Gaye, Oumar
    Tjitra, Emiliana
    Bojang, Kalifa
    Socheat, Duong
    Pioia, Patrice
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 287 - 287
  • [49] A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
    Smolen, Josef S.
    Agarwal, Sandeep K.
    Ilivanova, Elena
    Xu, Xie Lillian
    Miao, Ye
    Zhuang, Yanli
    Nnane, Ivo
    Radziszewski, Waldemar
    Greenspan, Andrew
    Beutler, Anna
    Baker, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (05) : 831 - 839
  • [50] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
    Mina Fathi-Kazerooni
    Samrand Fattah-Ghazi
    Maryam Darzi
    Jalil Makarem
    Reza Nasiri
    Faeze Salahshour
    Seyed Ali Dehghan-Manshadi
    Somaieh Kazemnejad
    Stem Cell Research & Therapy, 13
12345